Status:
RECRUITING
Optimizing Care for Cancer Survivors With Depression: Project 3
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to evaluate different depression treatment approaches among cancer survivors. A cancer survivor is defined as anyone who is living and has been diagnosed with can...
Detailed Description
Depression is Highly Prevalent Among Cancer Survivors and Novel Care Delivery Approaches are Needed. Nearly one in four cancer survivors suffer from depression, with negative sequalae including lower ...
Eligibility Criteria
Inclusion
- age 18+
- cancer survivor
- current elevated depressive symptoms defined per ASCO as a PHQ-9 score ≥ 8
- not currently receiving psychosocial depression treatment
- have the ability to complete treatment via telehealth and use Moodivate
- have a valid e-mail address or text message access (for assessments)
- English fluency
Exclusion
- \- Current suicidal ideation at final eligibility screening (PHQ-9 item 9 ≥1)
Key Trial Info
Start Date :
August 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06930729
Start Date
August 12 2025
End Date
May 15 2026
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425